Cambridge Investment Research Advisors’s CalciMedica CALC Stock Holding History

Cambridge Investment Research Advisors’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32K	Buy	+60,000	New	+$122K	﹤0.01%	3877
2025 Q2	–	Sell	-23,539	Closed	-$45K	–	3639
2025 Q1	$45K	Buy	+23,539	New	+$58.7K	﹤0.01%	3414

Other funds holding CALC

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Cambridge Investment Research Advisors's CALC Position: Q1 2026 in Review

Cambridge Investment Research Advisors opened a new position in CalciMedica (CALC) in Q1 2026: 60,000 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #3877 among its holdings. This is a return to the name: Cambridge Investment Research Advisors previously reported a position in CALC as recently as Q1 2025.

Cambridge Investment Research Advisors first reported a position in CALC in Q1 2025 and has held it in 2 quarters since. The position peaked at $45K in Q1 2025. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

Cambridge Investment Research Advisors held 60,000 shares of CalciMedica worth $32K as of Q1 2026.
CalciMedica was a new Cambridge Investment Research Advisors position in Q1 2026.
CalciMedica made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #3877 holding.
Cambridge Investment Research Advisors first reported a position in CalciMedica in Q1 2025 and has held it in 2 quarters since.
Cambridge Investment Research Advisors's CalciMedica position peaked at $45K in Q1 2025.
27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.